175 related articles for article (PubMed ID: 2170552)
21. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
Siemińska A
Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
[TBL] [Abstract][Full Text] [Related]
22. Soluble interleukin-2 receptor levels and immune activation in patients with schistosomiasis and carcinoma of the urinary bladder.
Raziuddin S; Shetty S; Ibrahim A
Scand J Immunol; 1992 Jun; 35(6):637-41. PubMed ID: 1604238
[TBL] [Abstract][Full Text] [Related]
23. Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancer.
Viviani S; Salvini PM; Bidoli P; Camerini E; Spinazzé S; Arienti F; Rivoltini L; Motta V
Int J Biol Markers; 1993; 8(1):21-4. PubMed ID: 8388428
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.
Prin L; Plumas J; Gruart V; Loiseau S; Aldebert D; Ameisen JC; Vermersch A; Fenaux P; Bletry O; Capron M
Blood; 1991 Nov; 78(10):2626-32. PubMed ID: 1726707
[TBL] [Abstract][Full Text] [Related]
25. The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients.
Kawashima O; Kamiyoshihara M; Sakata S; Endo K; Saito R; Morishita Y
Ann Surg Oncol; 2000 Apr; 7(3):239-45. PubMed ID: 10791856
[TBL] [Abstract][Full Text] [Related]
26. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T
Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
[TBL] [Abstract][Full Text] [Related]
27. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
[TBL] [Abstract][Full Text] [Related]
28. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
Song LH; Song XR; Liu MQ; Zhang XQ; Zheng L; Li XJ; Liu PX
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344
[TBL] [Abstract][Full Text] [Related]
30. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation.
Young JB; Windsor NT; Smart FW; Kleiman NS; Weilbaecher DG; Noon GP; Nelson DL; Lawrence EC
Transplantation; 1991 Mar; 51(3):636-41. PubMed ID: 2006520
[TBL] [Abstract][Full Text] [Related]
31. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
Liu X; An H; Jiang Y
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
[TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptors in the serum of patients with chronic renal failure.
Takamatsu T; Yasuda N; Ohno T; Kanoh T; Uchino H; Fujisawa A
Tohoku J Exp Med; 1988 Aug; 155(4):343-7. PubMed ID: 3068834
[TBL] [Abstract][Full Text] [Related]
33. Soluble interleukin-2 receptors in plasma cell dyscrasias.
Takamatsu T; Yasuda N; Ohno T; Kanoh T; Uchino H; Fujii H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):749-55. PubMed ID: 2618549
[TBL] [Abstract][Full Text] [Related]
34. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
Grutters JC; Fellrath JM; Mulder L; Janssen R; van den Bosch JM; van Velzen-Blad H
Chest; 2003 Jul; 124(1):186-95. PubMed ID: 12853522
[TBL] [Abstract][Full Text] [Related]
35. Soluble interleukin-2 receptor in patients with glomerular diseases.
Chen HS; Wu MS; Yen TS; Chen WY
Postgrad Med J; 1995 Oct; 71(840):617-22. PubMed ID: 8545291
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
37. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
Akiyama K; Tsuji M; Kurokawa Y; Yokota K; Kojima K; Naruo S; Kanayana HO; Kagawa S
Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):473-8. PubMed ID: 9155114
[TBL] [Abstract][Full Text] [Related]
38. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676
[TBL] [Abstract][Full Text] [Related]
39. The biological significance of soluble interleukin-2 receptors in solid tumors.
Lissoni P; Barni S; Rovelli F; Viviani S; Maestroni GJ; Conti A; Tancini G
Eur J Cancer; 1990 Jan; 26(1):33-6. PubMed ID: 2138475
[TBL] [Abstract][Full Text] [Related]
40. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
